Key statistics
On Monday, HUTCHMED (China) Ltd (13:HKG.HS) closed at 27.10, 42.63% above the 52 week low of 19.00 set on Feb 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 27.35 |
---|---|
High | 27.90 |
Low | 27.10 |
Bid | 27.10 |
Offer | 27.15 |
Previous close | 27.30 |
Average volume | 3.77m |
---|---|
Shares outstanding | 871.56m |
Free float | 501.29m |
P/E (TTM) | -- |
Market cap | 23.79bn HKD |
EPS (TTM) | -0.3887 HKD |
Data delayed at least 15 minutes, as of Nov 25 2024.
More ▼
Announcements
- FRUZAQLA® Launched in Japan by Takeda
- HUTCHMED Announces Launch by Takeda of FRUZAQLA® (fruquintinib) in Japan
- Appointment of Independent Non-executive Director
- HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee
- Clinical Data to be Presented at ASH and ESMO Asia
- HUTCHMED Highlights Clinical Data to be Presented at the 2024 ASH Annual Meeting and the 2024 ESMO Asia Congress
- First Commercial Milestone Payment
- Total Voting Rights
- HUTCHMED to Receive First Commercial Milestone Payment Following Over US$200 Million in FRUZAQLA® (fruquintinib) Sales by Takeda
- Vesting of awards under the LTIP
More ▼